GANNON STEVEN

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 38% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GANNON STEVEN's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-06 2025-06-05
S Sale
85,257 -3.3%
480.74
US$2,432,990 		85,257 -3.3% 480.74 US$2,432,990
2024-03-08 2024-03-07
S Sale
46,275 -30.3%
492.16
US$4,304,575 		46,275 -30.3% 492.16 US$4,304,575
2024-03-08 2024-03-07
S Sale
44,264 -8.0%
67.89
US$204,903 		44,264 -8.0% 67.89 US$204,903
2024-03-08 2024-03-07
S Sale
5,000 -35.7%
46.25
US$231,250 		5,000 -35.7% 46.25 US$231,250
2024-03-08 2024-03-07
S Sale
1,000 -6.7%
46.45
US$46,450 		1,000 -6.7% 46.45 US$46,450
2024-03-07 2024-03-07
PrS Proposed sale
13,000
46.18
US$600,310 		13,000 46.18 US$600,310
2022-08-11 2022-08-11
B Purchase
44,400 +370.0%
2.03
US$90,132 		44,400 +370.0% 2.03 US$90,132
2021-08-20 2021-08-19
B Purchase
3,000 +48.6%
8.05
US$24,150 		3,000 +48.6% 8.05 US$24,150
2021-08-20 2021-08-18
B Purchase
171 +2.9%
8.05
US$1,377 		171 +2.9% 8.05 US$1,377